pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    plogosertib
    plogosertib [INN]
    Bladder Cancer Tethra Biosciences Inc
  • Phase 2
    pocenbrodib hydrochloride
    pocenbrodib hydrochloride
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pathos AI Inc
  • Phase 2
    podentamig
    podentamig [INN]
    Refractory Multiple Myeloma$MRK Merck & Co., Inc.
  • Phase 2
← prev
page 55 of 62
next →
Pain89
Neurology1
polzastobart
polzastobart
Cutaneous Squamous Cell Carcinoma (cSCC)
Concentra Biosciences LLC
  • Marketed
    ponatinib hydrochloride
    Iclusig (ponatinib hydrochloride)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TAK TAKEDA PHARMACEUTICAL CO LTD
  • Marketed
    porfimer sodium
    Photofrin (porfimer sodium)
    Endobronchial Cancer Concordia Healthcare USA Inc
  • Phase 1
    potrasertib
    potrasertib [INN]
    Solid Tumor IMPACT Therapeutics Inc
  • Marketed
    pralatrexate
    Folotyn (pralatrexate)
    Peripheral T-Cell Lymphomas (PTCL) Fresenius Kabi USA LLC
  • Marketed
    pralsetinib
    Gavreto (pralsetinib [INN])
    Solid Tumor Blueprint Medicines Corp
  • Marketed
    prednisolone
    Prednisolone (prednisolone [INN])
    Allergic Conjunctivitis Teva Pharmaceuticals USA Inc
  • Marketed
    prednisolone sodium phosphate
    Prednisolone Sodium Phosphate
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Mission Pharmacal Co
  • Marketed
    prednisone
    Prednisone (prednisone [INN])
    Aspiration Pneumonitis Vintage Pharmaceuticals Inc (Inactive)
  • Phase 2
    prexasertib mesylate monohydrate
    prexasertib mesylate monohydrate
    Endometrial Cancer$ACRV Acrivon Therapeutics, Inc.
  • Phase 2
    prexigebersen
    prexigebersen
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$BPTH BIO-PATH HOLDINGS, INC.
  • Phase 1
    pritumumab
    pritumumab [INN]
    Anaplastic Astrocytoma Nascent Biotech Inc
  • Phase 2
    prizloncabtagene autoleucel
    prizloncabtagene autoleucel [INN]
    Diffuse Large B-Cell Lymphoma Janssen Biotech Inc
  • Marketed
    procarbazine hydrochloride
    Matulane (procarbazine hydrochloride)
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Leadiant Biosciences Inc
  • Phase 1
    prulacabtagene leucel
    prulacabtagene leucel
    B-Cell Non-Hodgkin Lymphoma$ACET Adicet Bio, Inc.
  • Phase 3
    pumitamig
    pumitamig [INN]
    Non-Small Cell Lung Cancer$BNTX BioNTech SE
  • Phase 2
    quaratusugene ozeplasmid
    Reqorsa (quaratusugene ozeplasmid)
    Non-Small Cell Lung Cancer$GNPX Genprex, Inc.
  • Phase 3
    quemliclustat
    quemliclustat
    Pancreatic Ductal Adenocarcinoma$RCUS Arcus Biosciences, Inc.
  • Phase 2
    radgocitabine
    radgocitabine [INN]
    Refractory Acute Myeloid Leukemia Delta-Fly Pharma Inc
  • Marketed
    radium Ra 223 dichloride
    Xofigo (radium Ra 223 dichloride)
    Bone Metastasis Bayer HealthCare Pharmaceuticals Inc
  • Phase 1
    ragistomig
    ragistomig [INN]
    Esophageal Cancer$NBP NovaBridge Biosciences
  • Marketed
    raloxifene hydrochloride
    Raloxifene Hydrochloride
    Post Menopausal Osteoporosis Modavar Pharmaceuticals LLC
  • Phase 3
    ramucirumab
    Cyramza (ramucirumab)
    Adenocarcinoma Of The Gastroesophageal Junction Eli Lilly and Co
  • Marketed
    ranitidine hydrochloride
    Ranitidine Hydrochloride
    Systemic Mastocytosis VKT Pharma Pvt Ltd
  • Phase 1
    ratangratinib
    ratangratinib [INN]
    Bile Duct Cancer (Cholangiocarcinoma) 3D Medicines Inc
  • Preclinical
    redaporfin
    redaporfin [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Luzitin SA
  • Marketed
    regorafenib
    Stivarga (regorafenib)
    Recurrent Glioblastoma Multiforme (GBM) Bayer AG